ASHLEY TETA: Open Payments
NPI 1518423490 · DEER PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,916 in 193 payments from 22 companies in 2025. Trend: 2023 $3,259 · 2024 $3,525 · 2025 $4,916
Food & beverage: $4,666Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $974 |
| Arcutis Biotherapeutics, Inc. | 18 | $792 |
| Lilly USA, LLC | 19 | $364 |
| Regeneron Healthcare Solutions, Inc. | 10 | $357 |
| LEO Pharma Inc. | 14 | $338 |
| Novartis Pharmaceuticals Corporation | 14 | $278 |
| GENZYME CORPORATION | 8 | $252 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $250 |
| Incyte Corporation | 12 | $244 |
| Galderma Laboratories, L.P. | 16 | $234 |
Products named: Zoryve, SKYRIZI, DUPIXENT, Neo-Synalar, EBGLYSS, OPZELURA, RINVOQ, COSENTYX.
Industry payments across NY — which companies pay providers there.
